Researchers connect severity of 'kissing disease' to T-cell population

December 5, 2017, American Society for Microbiology

Acute infectious mononucleosis (AIM), also known as mono or the "kissing disease," is caused by the Epstein-Barr Virus (EBV). In a paper published this week in mBio, researchers connect the onset and severity of mono to T-cells that react to both EBV and the influenza A virus, which causes the flu. The study represents one of the first reported links between how a person's immune system responds to infection and receptors on T-cells, which instigate the immune response.

A person's immune system remembers the -causing microbes it encounters over a lifetime. Each time a person is infected with some pathogen - like the influenza virus - T cells retain information. "You develop every time you have any infection," says pathologist and study leader Liisa Selin at the University of Massachusetts Medical School in Worcester, Mass. As a result, individuals develop cells with a heterogeneous mix of that evolves during their lifetime.

"Everybody has different memory cells with different T on them," says Selin, "even genetically identical twins." A person's repertoire of receptors, she says, "determines whether you get infectious mono or not."

Not everyone does. According to the Centers for Disease Control and Prevention, almost everyone - 95 percent of the world population - is infected with EBV by the time they reach 30. However, children infected with the virus rarely suffer the debilitating symptoms of mono, like fatigue, fever, and sore throat. Even some adults barely notice the infection. That may be because of their immune history: They don't have the specific receptors in those cross-reactive memory T cells that trigger a severe , Selin says.

She and her colleagues studied blood samples collected over a decade from college students: 32 diagnosed with mono, separated into two groups by severity of the disease, and 17 healthy controls who had tested positive for EBV. People with severe cases of mono had 25 times more T-cells that reacted to both Influenza A and EBV, per volume of blood, than the healthy controls. Similarly, people with mild cases had 10 times more of the cross-reactive T-cells than the EBV+ participants.

EBV is a tricky virus that can hide quietly for years - or even decades - in the tonsils, says Selin. The new work may help explain how a person's history of disease exposure can influence their susceptibility to disease.The findings suggest, for example, that a previous flu infection may make mono worse.

"If you have a lot of these flu memory T-cells in your tonsils and you get EBV, instead of silently hanging around, it activates those memory cells," says Selin. She hypothesizes that if young adults can avoid the flu, as by getting vaccinated, they might have fewer memory T-cells that were cross-reactive to influenza. As a result, they may be less likely to develop severe mono after EBV infection.

The findings reach beyond the kissing disease: EBV is associated with many autoimmune diseases, though the reasons why remain a mystery. Having infectious mono, for example, may increase a person's risk of developing multiple sclerosis.

The study adds to a growing body of research aimed at understanding the connections among T cell receptors, infectious disease outcomes and autoimmunity. A clear understanding this relationship, Selin says, may enable researchers to identify T- with specific receptors that can worsen the symptoms and pathology during an and may even sometimes lead to autoimmunity.

Explore further: Virus that causes mono may increase risk of MS for multiple races

Related Stories

Virus that causes mono may increase risk of MS for multiple races

August 30, 2017
Like whites, Hispanic and black people who have had mononucleosis, commonly known as mono, which is caused by Epstein-Barr virus, may have an increased risk of multiple sclerosis (MS), according to a new study published in ...

Researchers apply new immune technologies in search of mono vaccine

May 17, 2017
A research lab at the University of Kansas School of Engineering and School of Pharmacy is analyzing the genetics of human immune responses to develop the basis of an effective vaccine or drug therapy against Epstein-Barr ...

Immune system discovery could lead to EBV vaccine to prevent mono, some cancers

October 11, 2013
Development of a vaccine against Epstein-Barr virus (EBV) has taken a step forward with the Canadian discovery of how EBV infection evades detection by the immune system.

College students bringing home mononucleosis

December 6, 2013
One of the hallmarks of heading home for winter break is the enormous amount of laundry college students bring home as a present for mom and dad. But the dirty socks might not be the only unwelcome guest they transport home. ...

Dendritic cells 'divide and conquer' to elude viral infection while promoting immunity

July 7, 2017
A research team led by Jackson Laboratory (JAX) Professor Karolina Palucka, M.D., Ph.D., in collaboration with a research team at Institut Curie in France led by Dr. Nicolas Manel, have addressed a long-standing puzzle of ...

Young killer cells protect against infectious mononucleosis

December 19, 2013
More than 90 percent of all adults are carriers of the oncogenic Epstein-Barr Virus (EBV). Primary infection with this herpes virus as a young child is generally not linked to any symptoms, and usually offers life-long protection ...

Recommended for you

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Affordable Care Act: Study finds surprising gaps in HIV care providers' knowledge

September 20, 2018
A new study has revealed surprising gaps in some HIV medical providers' knowledge of the Affordable Care Act, with more than a quarter of providers surveyed unable to say whether their state had expanded Medicaid.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

Preventing a dengue outbreak at the 2020 Summer Olympics

September 20, 2018
In 2014, a dengue outbreak unexpectedly occurred in Tokyo. What does that mean for the 2020 summer Olympics and Paralympics being held in the city? Researchers report this week in PLOS Neglected Tropical Diseases that new ...

Researchers discover influenza virus doesn't replicate equally in all cells

September 19, 2018
The seasonal flu is caused by different subtypes of Influenza A virus and typically leads to the death of half a million people each year. In order to better understand this virus and how it spreads, University of Minnesota ...

Flu season forecasts could be more accurate with access to health care companies' data

September 19, 2018
In an era when for-profit companies collect a wealth of data about us, new research from The University of Texas at Austin shows that data collected by health care companies could—if made available to researchers and public ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.